(Reuters) – A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and those at high risk of illness, after rejecting a call for broader approval.
(Reporting By Peter Henderson; Editing by Bill Berkrot)